Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects

por Stefanie Fischer, Undine Proschmann, Katja Akgün, Tjalf Ziemssen
Publicado 2021

Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis

por Tobias Moser, Lena Hoepner, Kerstin Schwenker, Michael Seiberl, Julia Feige, Katja Akgün, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Publicado 2021

Digital Biomarkers in Multiple Sclerosis

por Anja Dillenseger, Marie Luise Weidemann, Katrin Trentzsch, Hernan Inojosa, Rocco Haase, Dirk Schriefer, Isabel Voigt, Maria Scholz, Katja Akgün, Tjalf Ziemssen
Publicado 2021